Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Abstract: Cancer immunotherapies have improved human health, and one among the important technologies for cancer immunotherapy is cancer vaccine. Antigens are the most important components in cancer vaccines. Generally, antigens in cancer vaccines can be divided into two categories: pre‐defined antigens and unidentified antigens. Although, cancer vaccines loaded with predefined antigens are commonly used, cancer vaccine loaded with mixed unidentified antigens, especially whole cancer cells or cancer cell lysates, is a very promising approach, and such vaccine can obviate some limitations in cancer vaccines. Their advantages include, but are not limited to, the inclusion of pan‐spectra (all or most kinds of) antigens, inducing pan‐clones specific T cells, and overcoming the heterogeneity of cancer cells. In this review, the recent advances in cancer vaccines based on whole‐tumor antigens, either based on whole cancer cells or whole cancer cell lysates, are summarized. In terms of whole cancer cell lysates, the focus is on applying whole water‐soluble cell lysates as antigens. Recently, utilizing the whole cancer cell lysates as antigens in cancer vaccines has become feasible. Considering that pre‐determined antigen‐based cancer vaccines (mainly peptide‐based or mRNA‐based) have various limitations, developing cancer vaccines based on whole‐tumor antigens is a promising alternative.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell ; day:31 ; month:05 ; year:2023 ; extent:23
Advanced science ; (31.05.2023) (gesamt 23)
- Urheber
-
Diao, Lu
Liu, Mi
- DOI
-
10.1002/advs.202300121
- URN
-
urn:nbn:de:101:1-2023060115015268110529
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Diao, Lu
- Liu, Mi
Ähnliche Objekte (12)
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
Technologies for circulating tumor cell separation from whole blood
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines
Photocatalytic Carbon Dots‐Triggered Pyroptosis for Whole Cancer Cell Vaccines
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
WholeCellViz: data visualization for whole-cell models
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
Technologies for circulating tumor cell separation from whole blood
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines
Photocatalytic Carbon Dots‐Triggered Pyroptosis for Whole Cancer Cell Vaccines
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
WholeCellViz: data visualization for whole-cell models
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
Technologies for circulating tumor cell separation from whole blood
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines
Photocatalytic Carbon Dots‐Triggered Pyroptosis for Whole Cancer Cell Vaccines
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer